PRN: Global Pharmaceutical Stability Testing Market Trends, Opportunities, and Future 2015-2020 - Market is Expected to Grow at a CAGR of 9.4% - Research-and-Markets

20/gen/2017 13:10:13 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Pharmaceutical Stability Testing Market Trends, Opportunities, and Future 2015-2020 - Market is Expected to Grow at a CAGR of 9.4% - Research-and-Markets

 
[20-January-2017]
 

DUBLIN, Jan 20, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Pharmaceutical Stability Testing Market Trends, Opportunities, and Future" report to their offering.

This research service on the global pharmaceutical stability testing market addresses market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market.

The base year is 2015 and forecasts are provided from 2016 to 2020. The market is expected to grow at a CAGR of 9.4% till 2020, driven by an explosion of new approval applications, consolidation, and globalization of both small and large molecule industries. Also, with the continuous growth of biologics, the global pharmaceutical stability testing market is expected to witness robust growth.

Biologics stability testing, being more complicated than that of small molecules, is expected to contribute significantly to overall revenue. Biopharmaceutical companies are consolidating stability storage and limiting testing to one facility whereas pharmaceutical companies are moving toward decentralized stability testing, and centralized management and reporting. These companies are opting for single stability storage deals and building strategic relationships with CROs. Also, they are looking for end-to-end services to outsource the entire development project to a single! CRO.

Early-stage biotech is identified as the largest growth segment for stability services, and has posted the highest increase during the past few years. For new-generation therapies and new trends in formulations such as non-aqueous and liposomal, many original study strategies apply but new strategies need to be adopted to deal with some of the nuances.

Asia-Pacific, especially India and China, is emerging as a big growth opportunity area for this market. Several large CROs are exploring acquisitions here. Many local participants in these markets provide specialized services for global participants. There is also high demand for stability testing for such products in the local markets.

Key Topics Covered:

1. Executive Summary

2. Key Findings

3. Scope and Segmentation

4. Market Overview

5. Market Revenue Forecast

6. Trends in Pharmaceutical Stability Testing Outsourcing

7. Trends in Pharmaceutical Stability Testing-Small and Large Molecules

8. Regional Trends in Stability Testing

9. Key Technology Trends

10. Analysis of Customer Base

11. Growth Opportunities

12. Company Profiles

-! Charles River Laboratories
- Eurofins Scientific
- Intertek
- BioReliance

For more information about this report visit http://www.researchandmarkets.com/research/6blkrp/global

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl